Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Epithalon is not FDA-approved as a pharmaceutical treatment for any indication
The Air Force has removed all of it topics from the 25.2/B OSD SBIR/STTR solicitation "while they undergo internal review to ensure alignment with program goals and priorities"
No phase II or III randomised controlled trials have been registered with the EMA, MHRA or FDA
a landmark study in the Journal of Investigative Dermatology demonstrated that topical or intraperitoneal thymosin beta-4 increased rat wound reepithelialization by 42% at day 4 and up to 61% at day 7 versus saline controls, with increased collagen deposition and angiogenesis also documented
US$ 24.83
US$ 27.97
US$ 23.02
US$ 28.86
US$ 25.97
US$ 27.00
